Bernstein Initiates Coverage On Amgen with Outperform Rating, Announces Price Target of $380

Benzinga · 10/17 11:33
Bernstein analyst Aaron Gal initiates coverage on Amgen (NASDAQ:AMGN) with a Outperform rating and announces Price Target of $380.